Antibodies to insulin receptors purified from rat liver membranes do not complete with [ 125 I]insulin for binding to the insulin receptor but do precipitate solubilized receptors labeled with [ 125 I]insulin. These antibodies have the insulin-like activities of enhancing glucose oxidation and inhibiting epinephrine-induced lipolysis in rat adipocytes. Thus, antibody binds to the receptor at a different site from that to which insulin binds, yet the interaction can initiate an effective biological response. These results indicate that the previously studied insulin-binding sites are the physiological macromolecular receptors for insulin.
No takes yet. Share an insight, caveat, or question.
Jacobs et al. (1978) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: